- $1.96m
- $0.56m
- $8.86m
Annual income statement for Nuwellis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.51 | 7.44 | 7.92 | 8.54 | 8.86 |
Cost of Revenue | |||||
Gross Profit | 2.85 | 4.06 | 4.49 | 4.75 | 4.98 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 23.6 | 24.5 | 27.4 | 25.7 | 26.5 |
Operating Profit | -18.1 | -17 | -19.5 | -17.2 | -17.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18.1 | -15.8 | -19.5 | -14.5 | -20.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -18.1 | -15.8 | -19.6 | -14.5 | -20.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -18.1 | -15.8 | -19.6 | -14.5 | -20.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -22.6 | -17.6 | -19.6 | -14.5 | -22.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -27,895 | -1,067 | -284 | -83.5 | -11.5 |